Waters Corp (WAT) 119.86 $WAT
Shares of WAT Up 14.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 12, 10:22AM CST
SmarTrend identified an Uptrend for Waters (NYSE:WAT) on October 21st, 2014 at $103.89. In approximately 4 months, Waters has returned 14.73% as of today's recent price of $119.20.
WAT: 119.86 (+0.71)
Waters Corporation Presentation at the Leerink 2015 Global Healthcare Conference to Be Audio Webcast Live
Business Wire - Thu Feb 05, 12:58PM CST
Waters Corporation (NYSE:WAT) Gene Cassis, Chief Financial Officer, will speak to the investment community at the Leerink 2015 Global Healthcare Conference at the Waldorf Astoria Hotel in New York City on Thursday, February 12, at 10:20 a.m. eastern time.
WAT: 119.86 (+0.71)
Waters Shares Up 14.7% Since SmarTrend's Buy Recommendation (WAT)
Comtex SmarTrend(R) - Wed Feb 04, 5:19PM CST
SmarTrend identified an Uptrend for Waters (NYSE:WAT) on October 21st, 2014 at $103.89. In approximately 4 months, Waters has returned 14.67% as of today's recent price of $119.13.
WAT: 119.86 (+0.71)
The Road Ahead: Special Research on Vivint Solar, Voxeljet, Wabash, Wabco and Waters
PR Newswire - Mon Feb 02, 7:50AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Vivint Solar (NYSE: VSLR), Voxeljet (NYSE: VJET), Wabash (NYSE: WNC), Wabco (NYSE: WBC), and Waters (NYSE: WAT). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
VJET: 10.40 (+0.45), VSLR: 8.39 (+0.06), WNC: 14.01 (+0.38), WBC: 109.54 (+6.48), WAT: 119.86 (+0.71)
Week In Review: MicroConstants Pays $16 Million For Novel China Antibody
ChinaBio Today - at Seeking Alpha - Sun Feb 01, 10:02AM CST
Deals and Financings MicroConstants China in-licensed global rights to novel discovered-in-China AA98 antibodies from Beijing's Institute of Biophysics, Chinese Academy of Sciences. With anti-angiogenesis and anti-metastasis mechanisms, AA98...
WAT: 119.86 (+0.71)
Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019
M2 - Fri Jan 30, 11:42PM CST
Research and Markets (http://www.researchandmarkets.com/research/8mr9p9/protein) has announced the addition of the "Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019" report to their offering. The global protein characterization and identification market was valued at $1.56 billion in 2014, and is expected to grow at a CAGR of 10.63% to reach $2.6 billion in 2019 The marketing automation software is a sales and marketing tool that helps the company to nurture leads with their likes and dislikes and turn the customers into delighted customers. The software understands the leads behaviour and on that behaviour do scoring and converting into quality leads to the sales team. The software broadly focuses on range of automation and analytic tool for sales and marketing activities through multiple online channels. The major factors that is driving the Marketing Automation Software market is the need of marketing accountability, third-party application ecosystem, and growth in multiple online channels is enhancing the market globally. These drivers are creating demand of the software across various verticals. The major factors which are restricting the growth of Marketing Automation Software market are open source solution, technology shift, and data privacy. Furthermore there are even few challenges like providing customer specific solution to every organisation. There are various assumptions that have been taken into consideration for market sizing and forecasting exercise. Few of global assumptions include political, economic, social, technological and economic factors. For instance, economic factor such as exchange rates are expected to have a moderate rating of impact on this market. Therefore, dollar fluctuations are not expected to seriously affect the forecasts in the emerging APAC and LA regions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Protein Characterization and Identification Market, By Application 8 Protein Characterization and Identification Market, By Product 9 Protein Characterization and Identification Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Bruker Corporation - Danaher Corporation - General Electric - Perkinelmer, Inc. - Shimadzu Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/8mr9p9/protein
A: 40.15 (+0.13), SIAL: 138.20 (+0.07), DHR: 86.81 (+0.21), WAT: 119.86 (+0.71)
Waters Corp. (WAT) Stock Gained Today After Cantor Fitzgerald Increased Price Target
at The Street - Wed Jan 28, 4:13PM CST
Shares of Waters Corp. (WAT) closed slightly higher today following Cantor Fitzgerald's increased price target to $133 from $123.
WAT: 119.86 (+0.71)
Waters Has Returned 14.7% Since SmarTrend Recommendation (WAT)
Comtex SmarTrend(R) - Wed Jan 28, 11:22AM CST
SmarTrend identified an Uptrend for Waters (NYSE:WAT) on October 21st, 2014 at $103.89. In approximately 3 months, Waters has returned 14.68% as of today's recent price of $119.14.
WAT: 119.86 (+0.71)
Joint Open Laboratory Established In China by Waters & the Chinese Pharmacopeia Commission
PR Newswire - Wed Jan 28, 7:00AM CST
Waters® Corporation (NYSE: WAT) recently announced the inauguration of its Joint Open Laboratory established together with the Chinese Pharmacopeia Commission (ChP) during an opening ceremony held in Beijing.
WAT: 119.86 (+0.71)
Waters Rises 2.79% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jan 27, 5:17PM CST
Waters (NYSE:WAT) traded in a range yesterday that spanned from a low of $116.51 to a high of $122.80. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $116.48 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WAT: 119.86 (+0.71)
After Yesterday's Rally of 2.79% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Jan 27, 5:16PM CST
Waters (NYSE:WAT) traded in a range yesterday that spanned from a low of $116.51 to a high of $122.80. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $116.48 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WAT: 119.86 (+0.71)
Waters (WAT) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Tue Jan 27, 1:21PM CST
The following Waters (WAT) conference call took place on January 27, 2015, 08:30 AM ET. This is a transcript of that earnings call:
WAT: 119.86 (+0.71)
Waters' (WAT) CEO Douglas Berthiaume on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Jan 27, 11:13AM CST
WAT: 119.86 (+0.71)
3 Health Care Stocks Pushing The Sector Higher
at The Street - Tue Jan 27, 11:07AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.
AZN: 69.96 (+0.20), WAT: 119.86 (+0.71), NVS: 102.20 (-0.17)
Waters Transforms Glycan Analysis with New UPLC and UPLC-MS Analytical Workflows
Business Wire - Tue Jan 27, 9:19AM CST
Waters Corporation (NYSE:WAT) today announced ground-breaking new technology for characterizing glycoproteins. The technology introduction at WCBP 2015, includes the new GlycoWorks(TM) RapiFluor-MS N-Glycan Kit, the Waters(R) ACQUITY UPLC(R), the ACQUITY(R) UPLC FLR Detector and the ACQUITY QDa(R) detector, and enables scientists to analyze released N-glycans and achieve new levels of speed, sensitivity, simplicity while obtaining previously unattainable structural information.
WAT: 119.86 (+0.71)
Waters Beats on Q4 Estimates on Surging Pharma Demand - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 27, 8:34AM CST
Waters Corporation (WAT) reported fourth-quarter 2014 non-GAAP earnings of $1.99 per share, beating the Zacks Consensus Estimate of $1.89 by 5.3%.
ACIW: 20.65 (+0.59), ACLS: 2.81 (+0.04), AAPL: 127.08 (+0.62), WAT: 119.86 (+0.71)
Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 4:30PM CST
MMM: 165.94 (+0.03), ABMD: 60.39 (+0.46), LMT: 196.95 (-0.53), FCX: 20.29 (+0.82), AKS: 4.87 (+0.39), DHR: 86.81 (+0.21), AOS: 62.76 (+0.10), FMER: 18.27 (+0.17), COH: 39.85 (+0.64), SNV: 28.12 (-0.02), AAL: 48.39 (+0.51), DD: 76.18 (-0.11), CAT: 85.13 (+1.60), AVX: 13.95 (+0.29), AUDC: 5.44 (+0.22), PII: 156.00 (+1.89), PHG: 28.93 (-0.07), NUE: 48.90 (+0.55), PFE: 34.64 (-0.23), FCFS: 48.92 (+0.25), BMY: 60.04 (+0.56), GLW: 25.00 (+0.14), PLD: 43.81 (-0.96), ITW: 98.26 (+0.48), WAT: 119.86 (+0.71), NEE: 103.62 (-1.72), ISSI: 17.13 (+0.35), BTU: 7.65 (+0.46), PH: 124.06 (+2.23), ERIC: 12.77 (-0.02), AMG: 215.77 (+1.21), TDG: 208.62 (+1.96), IIVI: 17.40 (+0.09), DOV: 74.41 (+1.13), PG: 85.90 (-0.13), CIT: 46.17 (-0.36), OSK: 46.70 (+0.69), NVS: 102.20 (-0.17), LXK: 44.70 (+0.43)
Waters beats Street 4Q forecasts
Automated Insights - Mon Jan 26, 4:01PM CST
MILFORD, Mass. (AP) _ Waters Corp. (WAT) on Monday reported fourth-quarter profit of $151.3 million.
WAT: 119.86 (+0.71)
Waters beats by $0.10, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 3:30PM CST
WAT: 119.86 (+0.71)
Waters earnings up 9% in Q4
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 3:21PM CST
WAT: 119.86 (+0.71)
Shares of WAT Up 14.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 12, 10:22AM CST
SmarTrend identified an Uptrend for Waters (NYSE:WAT) on October 21st, 2014 at $103.89. In approximately 4 months, Waters has returned 14.73% as of today's recent price of $119.20.
WAT: 119.86 (+0.71)
Waters Corporation Presentation at the Leerink 2015 Global Healthcare Conference to Be Audio Webcast Live
Business Wire - Thu Feb 05, 12:58PM CST
Waters Corporation (NYSE:WAT) Gene Cassis, Chief Financial Officer, will speak to the investment community at the Leerink 2015 Global Healthcare Conference at the Waldorf Astoria Hotel in New York City on Thursday, February 12, at 10:20 a.m. eastern time.
WAT: 119.86 (+0.71)
Waters Shares Up 14.7% Since SmarTrend's Buy Recommendation (WAT)
Comtex SmarTrend(R) - Wed Feb 04, 5:19PM CST
SmarTrend identified an Uptrend for Waters (NYSE:WAT) on October 21st, 2014 at $103.89. In approximately 4 months, Waters has returned 14.67% as of today's recent price of $119.13.
WAT: 119.86 (+0.71)
The Road Ahead: Special Research on Vivint Solar, Voxeljet, Wabash, Wabco and Waters
PR Newswire - Mon Feb 02, 7:50AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Vivint Solar (NYSE: VSLR), Voxeljet (NYSE: VJET), Wabash (NYSE: WNC), Wabco (NYSE: WBC), and Waters (NYSE: WAT). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
VJET: 10.40 (+0.45), VSLR: 8.39 (+0.06), WNC: 14.01 (+0.38), WBC: 109.54 (+6.48), WAT: 119.86 (+0.71)
Week In Review: MicroConstants Pays $16 Million For Novel China Antibody
ChinaBio Today - at Seeking Alpha - Sun Feb 01, 10:02AM CST
Deals and Financings MicroConstants China in-licensed global rights to novel discovered-in-China AA98 antibodies from Beijing's Institute of Biophysics, Chinese Academy of Sciences. With anti-angiogenesis and anti-metastasis mechanisms, AA98...
WAT: 119.86 (+0.71)
Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019
M2 - Fri Jan 30, 11:42PM CST
Research and Markets (http://www.researchandmarkets.com/research/8mr9p9/protein) has announced the addition of the "Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019" report to their offering. The global protein characterization and identification market was valued at $1.56 billion in 2014, and is expected to grow at a CAGR of 10.63% to reach $2.6 billion in 2019 The marketing automation software is a sales and marketing tool that helps the company to nurture leads with their likes and dislikes and turn the customers into delighted customers. The software understands the leads behaviour and on that behaviour do scoring and converting into quality leads to the sales team. The software broadly focuses on range of automation and analytic tool for sales and marketing activities through multiple online channels. The major factors that is driving the Marketing Automation Software market is the need of marketing accountability, third-party application ecosystem, and growth in multiple online channels is enhancing the market globally. These drivers are creating demand of the software across various verticals. The major factors which are restricting the growth of Marketing Automation Software market are open source solution, technology shift, and data privacy. Furthermore there are even few challenges like providing customer specific solution to every organisation. There are various assumptions that have been taken into consideration for market sizing and forecasting exercise. Few of global assumptions include political, economic, social, technological and economic factors. For instance, economic factor such as exchange rates are expected to have a moderate rating of impact on this market. Therefore, dollar fluctuations are not expected to seriously affect the forecasts in the emerging APAC and LA regions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Protein Characterization and Identification Market, By Application 8 Protein Characterization and Identification Market, By Product 9 Protein Characterization and Identification Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Bruker Corporation - Danaher Corporation - General Electric - Perkinelmer, Inc. - Shimadzu Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/8mr9p9/protein
A: 40.15 (+0.13), SIAL: 138.20 (+0.07), DHR: 86.81 (+0.21), WAT: 119.86 (+0.71)
Waters Corp. (WAT) Stock Gained Today After Cantor Fitzgerald Increased Price Target
at The Street - Wed Jan 28, 4:13PM CST
Shares of Waters Corp. (WAT) closed slightly higher today following Cantor Fitzgerald's increased price target to $133 from $123.
WAT: 119.86 (+0.71)
Waters Has Returned 14.7% Since SmarTrend Recommendation (WAT)
Comtex SmarTrend(R) - Wed Jan 28, 11:22AM CST
SmarTrend identified an Uptrend for Waters (NYSE:WAT) on October 21st, 2014 at $103.89. In approximately 3 months, Waters has returned 14.68% as of today's recent price of $119.14.
WAT: 119.86 (+0.71)
Joint Open Laboratory Established In China by Waters & the Chinese Pharmacopeia Commission
PR Newswire - Wed Jan 28, 7:00AM CST
Waters® Corporation (NYSE: WAT) recently announced the inauguration of its Joint Open Laboratory established together with the Chinese Pharmacopeia Commission (ChP) during an opening ceremony held in Beijing.
WAT: 119.86 (+0.71)
Waters Rises 2.79% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jan 27, 5:17PM CST
Waters (NYSE:WAT) traded in a range yesterday that spanned from a low of $116.51 to a high of $122.80. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $116.48 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WAT: 119.86 (+0.71)
After Yesterday's Rally of 2.79% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Jan 27, 5:16PM CST
Waters (NYSE:WAT) traded in a range yesterday that spanned from a low of $116.51 to a high of $122.80. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $116.48 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WAT: 119.86 (+0.71)
Waters (WAT) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Tue Jan 27, 1:21PM CST
The following Waters (WAT) conference call took place on January 27, 2015, 08:30 AM ET. This is a transcript of that earnings call:
WAT: 119.86 (+0.71)
Waters' (WAT) CEO Douglas Berthiaume on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Jan 27, 11:13AM CST
WAT: 119.86 (+0.71)
3 Health Care Stocks Pushing The Sector Higher
at The Street - Tue Jan 27, 11:07AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.
AZN: 69.96 (+0.20), WAT: 119.86 (+0.71), NVS: 102.20 (-0.17)
Waters Transforms Glycan Analysis with New UPLC and UPLC-MS Analytical Workflows
Business Wire - Tue Jan 27, 9:19AM CST
Waters Corporation (NYSE:WAT) today announced ground-breaking new technology for characterizing glycoproteins. The technology introduction at WCBP 2015, includes the new GlycoWorks(TM) RapiFluor-MS N-Glycan Kit, the Waters(R) ACQUITY UPLC(R), the ACQUITY(R) UPLC FLR Detector and the ACQUITY QDa(R) detector, and enables scientists to analyze released N-glycans and achieve new levels of speed, sensitivity, simplicity while obtaining previously unattainable structural information.
WAT: 119.86 (+0.71)
Waters Beats on Q4 Estimates on Surging Pharma Demand - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 27, 8:34AM CST
Waters Corporation (WAT) reported fourth-quarter 2014 non-GAAP earnings of $1.99 per share, beating the Zacks Consensus Estimate of $1.89 by 5.3%.
ACIW: 20.65 (+0.59), ACLS: 2.81 (+0.04), AAPL: 127.08 (+0.62), WAT: 119.86 (+0.71)
Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 4:30PM CST
MMM: 165.94 (+0.03), ABMD: 60.39 (+0.46), LMT: 196.95 (-0.53), FCX: 20.29 (+0.82), AKS: 4.87 (+0.39), DHR: 86.81 (+0.21), AOS: 62.76 (+0.10), FMER: 18.27 (+0.17), COH: 39.85 (+0.64), SNV: 28.12 (-0.02), AAL: 48.39 (+0.51), DD: 76.18 (-0.11), CAT: 85.13 (+1.60), AVX: 13.95 (+0.29), AUDC: 5.44 (+0.22), PII: 156.00 (+1.89), PHG: 28.93 (-0.07), NUE: 48.90 (+0.55), PFE: 34.64 (-0.23), FCFS: 48.92 (+0.25), BMY: 60.04 (+0.56), GLW: 25.00 (+0.14), PLD: 43.81 (-0.96), ITW: 98.26 (+0.48), WAT: 119.86 (+0.71), NEE: 103.62 (-1.72), ISSI: 17.13 (+0.35), BTU: 7.65 (+0.46), PH: 124.06 (+2.23), ERIC: 12.77 (-0.02), AMG: 215.77 (+1.21), TDG: 208.62 (+1.96), IIVI: 17.40 (+0.09), DOV: 74.41 (+1.13), PG: 85.90 (-0.13), CIT: 46.17 (-0.36), OSK: 46.70 (+0.69), NVS: 102.20 (-0.17), LXK: 44.70 (+0.43)
Waters beats Street 4Q forecasts
Automated Insights - Mon Jan 26, 4:01PM CST
MILFORD, Mass. (AP) _ Waters Corp. (WAT) on Monday reported fourth-quarter profit of $151.3 million.
WAT: 119.86 (+0.71)
Waters beats by $0.10, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 3:30PM CST
WAT: 119.86 (+0.71)
Waters earnings up 9% in Q4
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 3:21PM CST
WAT: 119.86 (+0.71)
